Cardinal Health Inc
CAHNYSECIK 721371Consumer discretionaryFiscal year ends Jun 30
Reports and events: 314 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0110:52 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-26-000041 |
| 2026-09-2120:15 ET | DEF 14A | Proxy statementPeriod 2026-11-12 | 0001308179-26-000402 |
| 2026-08-1112:57 ET | 10-K | Annual reportPeriod 2026-06-30 | 0000721371-26-000038 |
| 2026-08-1110:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-26-000037 |
| 2026-08-1110:38 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000721371-26-000036 |
| 2026-08-0510:39 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000721371-26-000026 |
| 2026-04-3012:51 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0000721371-26-000018 |
| 2026-04-3010:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-26-000017 |
| 2026-03-2310:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-26-000013 |
| 2026-03-0512:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000721371-26-000010 |
| 2026-02-0513:47 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0000721371-26-000006 |
| 2026-02-0511:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-26-000004 |
| 2026-01-1311:53 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-26-000003 |
| 2025-11-0621:13 ET | 8-K | 5.07 Shareholder vote results | 0000721371-25-000133 |
| 2025-10-3012:48 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0000721371-25-000130 |
| 2025-10-3010:52 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-25-000128 |
| 2025-10-1010:33 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000721371-25-000125 |
| 2025-10-0310:25 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000721371-25-000122 |
| 2025-09-1610:25 ET | DEF 14A | Proxy statementPeriod 2025-11-05 | 0000721371-25-000114 |
| 2025-08-2721:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-189845 |
| 2025-08-1421:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-180900 |
| 2025-08-1212:58 ET | 10-K | Annual reportPeriod 2025-06-30 | 0000721371-25-000079 |
| 2025-08-1210:59 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-25-000075 |
| 2025-06-1210:47 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-25-000053 |
| 2025-05-0112:53 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000721371-25-000038 |
| 2025-05-0110:49 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-25-000036 |
| 2025-03-1010:53 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-25-000020 |
| 2025-01-3013:48 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0000721371-25-000013 |
| 2025-01-3011:51 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-25-000009 |
| 2025-01-1411:45 ET | 8-K | 7.01 Regulation FD disclosure | 0000721371-25-000003 |
| 2024-12-0911:21 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000721371-24-000169 |
| 2024-11-2221:46 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-264393 |
| 2024-11-1811:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-260394 |
| 2024-11-1211:20 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-255062 |
| 2024-11-0721:14 ET | 8-K | 5.07 Shareholder vote results | 0000721371-24-000132 |
| 2024-11-0112:58 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000721371-24-000121 |
| 2024-11-0110:47 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-24-000119 |
| 2024-10-1010:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000721371-24-000112 |
| 2024-09-1620:12 ET | DEF 14A | Proxy statementPeriod 2024-11-06 | 0000721371-24-000103 |
| 2024-09-0910:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000721371-24-000092 |
| 2024-08-1412:47 ET | 10-K | Annual reportPeriod 2024-06-30 | 0000721371-24-000056 |
| 2024-08-1410:36 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-24-000054 |
| 2024-05-0212:47 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000721371-24-000038 |
| 2024-05-0210:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-24-000036 |
| 2024-04-2310:42 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-24-000030 |
| 2024-04-2210:48 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-24-000026 |
| 2024-02-2821:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000721371-24-000012 |
| 2024-02-2021:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-040017 |
| 2024-02-0113:54 ET | 10-Q | Quarterly reportPeriod 2023-12-31 | 0001628280-24-002813 |
| 2024-02-0112:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-002805 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:55 ET. Listed shows no prices and gives no investment advice.